Institutional investors purchased a net $618.9 thousand shares of DEPO during the quarter ended December 2017 and now own 93.12% of the total shares outstanding. This majority interest is a greater percentage than is typical for companies in the Pharmaceuticals: Other industry and highlights that the smart money sees this stock as an important holding.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
RENAISSANCE TECHNOLOGIES LLC Bought 1.7 Million shares of Depomed Inc
CONNOR, CLARK & LUNN INVESTMENT ... Bought 837.7 Thousand shares of Depomed Inc